Skip to main content

What the FDA labels say about taking them together

Dabigatran and verapamil

Dabigatran's FDA label of June 25, 2025 names verapamil in its drug interactions section; the verapamil labels PlainMeds reads (4) do not name dabigatran. The dabigatran label: “The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dosage adjustment of PRADAXA.”

Check it at the source: the dabigatran FDA label on DailyMed (effective June 25, 2025, Boehringer Ingelheim Pharmaceuticals Inc.); the verapamil FDA label on DailyMed (effective April 6, 2026, Zydus Pharmaceuticals (USA) Inc.).

What does the dabigatran label say about verapamil?

Dabigatran label, drug interactions

The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dosage adjustment of PRADAXA.

Source: FDA drug label (Pradaxa), Boehringer Ingelheim Pharmaceuticals Inc., effective June 25, 2025 (SPL set ba74e3cd-b06f-4145-b284-5fd6b84ff3c9), via openFDA; the full label on DailyMed

What does the verapamil label say about dabigatran?

Verapamil's label (effective April 6, 2026) and its 3 other brand-application labels do not name dabigatran in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Verapamil hydrochloride), Zydus Pharmaceuticals (USA) Inc., effective April 6, 2026 (SPL set e19ab8d8-dae5-489d-9805-7e7407bea06d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Dabigatran generic labelers
43Verapamil generic labelers
DabigatranVerapamil
Labeled forAtrial fibrillation, Blood clots (DVT and PE), Stroke preventionHigh blood pressure, Atrial fibrillation, Angina
Boxed warningYesNo
Pharmacy cost (NADAC)$0.795 per capsule 150 mg capsule$0.191 per tablet 180 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?